Đang chuẩn bị liên kết để tải về tài liệu:
VAReporter: Variant reporter for cancer research of massive parallel sequencing

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG Tải xuống

High throughput sequencing technologies have been an increasingly critical aspect of precision medicine owing to a better identification of disease targets, which contributes to improved health care cost and clinical outcomes. In particular, disease-oriented targeted enrichment sequencing is becoming a widely-accepted application for diagnostic purposes, which can interrogate known diagnostic variants as well as identify novel biomarkers from panels of entire human coding exome or disease-associated genes. |